| 1 |
34165800 | The Role of Pharmacogenetics in Smoking. | 2021 Sep |
1 |
| 2 |
33329709 | Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation. | 2020 |
1 |
| 3 |
30906561 | Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes. | 2019 Apr |
12 |
| 4 |
27750412 | Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes. | 2017 Jan 17 |
1 |
| 5 |
25409894 | Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo. | 2015 Feb |
3 |
| 6 |
25489907 | CYP2B6 gene single-nucleotide polymorphisms in an Italian population sample and relationship with nicotine dependence. | 2015 Feb |
8 |
| 7 |
25652250 | Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration. | 2015 Jul |
10 |
| 8 |
25655887 | Pharmacogenetics of nicotine and associated smoking behaviors. | 2015 |
1 |
| 9 |
23591849 | Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. | 2013 Apr 16 |
1 |
| 10 |
23639433 | Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys. | 2013 Sep |
5 |
| 11 |
24260284 | CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes. | 2013 |
4 |
| 12 |
22569203 | CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. | 2012 Jun |
3 |
| 13 |
21266057 | Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. | 2011 Jan 25 |
1 |
| 14 |
20307138 | Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. | 2010 Jun |
1 |
| 15 |
16309716 | CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment. | 2006 Mar |
8 |
| 16 |
16135656 | CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions. | 2005 Dec |
3 |
| 17 |
15364541 | PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. | 2004 Sep 15 |
1 |
| 18 |
12814665 | Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. | 2003 Jul |
3 |
| 19 |
12439223 | Pharmacogenetic investigation of smoking cessation treatment. | 2002 Nov |
1 |
| 20 |
10350185 | Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. | 1999 Mar |
3 |
| 21 |
1680658 | Metabolism of nicotine by rat liver cytochromes P-450. Assessment utilizing monoclonal antibodies to nicotine and cotinine. | 1991 Jul-Aug |
5 |